Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
29.09.23
/
50%
€11.70
Target price
29.09.24
€17.92
Performance (%)
-19.23%
End price
30.09.24
€9.45
Summary
This prediction ended on 30.09.24 with a price of €9.45. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -19.23%. JPMorgan_Chase___Co_ has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -1.554% | -1.554% | -9.524% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.40
16.08.24
16.08.24
€14.55
16.08.25
16.08.25
-7.21%
03.10.24
03.10.24
